Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Akros Pharma Inc.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A diagnosis of RA prior to the Screening Visit.
Active disease despite ongoing therapy with up to two non-biologic disease-modifying anti-rheumatic drugs, including methotrexate at both the Screening and Baseline Visits.
Screening hs-CRP ≥1.2 x upper limit of normal (ULN).
You may not be if
Prior/current exposure to biologic and/or kinase inhibitor therapy.
Known history or presence of polyneuropathy of any cause and no presence of clinically active compression neuropathy, radiculopathy or plexopathy at the Screening Visit.
Positive test results for human immunodeficiency (HIV) virus, hepatitis B virus or hepatitis C (HCV) virus at the Screening Visit.
Positive drug of abuse and alcohol test results.
History of a clinically-significant infection that required oral antimicrobial or antiviral therapy within 8 weeks prior to Day 1.
